{
  "id": "9ed6f8ae57f884d2",
  "title": "NAD+ supplement shows early promise for long COVID fatigue and brain fog",
  "description": "Long COVID still affects people worldwide with stubborn symptoms like fatigue and cognitive issues. A clinical trial tested whether boosting NAD+ using nicotinamide riboside could help. Although overall group differences were limited, many participants showed encouraging improvements after taking NR for at least 10 weeks. The findings suggest NAD+ enhancement may offer symptom relief for some individuals.",
  "content": "Long COVID still affects people worldwide with stubborn symptoms like fatigue and cognitive issues. A clinical trial tested whether boosting NAD+ using nicotinamide riboside could help. Although overall group differences were limited, many participants showed encouraging improvements after taking NR for at least 10 weeks. The findings suggest NAD+ enhancement may offer symptom relief for some individuals.",
  "source": "Health & Medicine News -- ScienceDaily",
  "source_url": "https://www.sciencedaily.com/releases/2025/12/251211100629.htm",
  "published_at": "2025-12-12T03:42:25+00:00",
  "fetched_at": "2025-12-13T00:21:55.936102+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "ai",
    "aging"
  ],
  "location": null,
  "raw_data": {
    "title": "NAD+ supplement shows early promise for long COVID fatigue and brain fog",
    "description": "Long COVID still affects people worldwide with stubborn symptoms like fatigue and cognitive issues. A clinical trial tested whether boosting NAD+ using nicotinamide riboside could help. Although overall group differences were limited, many participants showed encouraging improvements after taking NR for at least 10 weeks. The findings suggest NAD+ enhancement may offer symptom relief for some individuals.",
    "url": "https://www.sciencedaily.com/releases/2025/12/251211100629.htm",
    "published": "2025-12-12T03:42:25+00:00",
    "source": "Health & Medicine News -- ScienceDaily"
  }
}